News

TipRanks on MSN19h

Pfizer’s Phase 2 Study on PF-06835375: A Potential Breakthrough in ITP Treatment

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 2, open-label, multicenter study titled ...
The American Journal of Managed Care21h

Defining Treatment Success, Failure, and When to Reassess Patients’ Management of ITP

An expert discusses how ITP treatment success is monitored through maintaining safe platelet levels and symptom control, ...
The American Journal of Managed Care21h

Risks versus Benefits: ITP Treatment Side Effects and the Influence on Patients’ Quality of Life

An expert discusses the importance of balancing efficacy with safety in ITP treatment, emphasizing cautious use of steroids, close monitoring of therapy-related side effects, and maintaining platelet ...